[Unstable angina: efficacy and tolerability of therapy with aspirin and aspirin combined with ticlopidine]. 2007

A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000789 Angina, Unstable Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION. Angina at Rest,Angina, Preinfarction,Myocardial Preinfarction Syndrome,Angina Pectoris, Unstable,Unstable Angina,Angina Pectori, Unstable,Anginas, Preinfarction,Anginas, Unstable,Myocardial Preinfarction Syndromes,Preinfarction Angina,Preinfarction Anginas,Preinfarction Syndrome, Myocardial,Preinfarction Syndromes, Myocardial,Syndrome, Myocardial Preinfarction,Syndromes, Myocardial Preinfarction,Unstable Angina Pectori,Unstable Angina Pectoris,Unstable Anginas
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013988 Ticlopidine An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. 53-32C,Ticlid,Ticlodix,Ticlodone,Ticlopidine Hydrochloride,53 32C,5332C,Hydrochloride, Ticlopidine

Related Publications

A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
July 1990, Circulation,
A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
December 1990, Circulation,
A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
January 2001, Terapevticheskii arkhiv,
A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
December 1996, Circulation,
A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
May 1991, Thrombosis and haemostasis,
A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
March 2000, The American journal of cardiology,
A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
July 1986, British medical journal (Clinical research ed.),
A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
December 1985, Circulation,
A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
December 1991, European heart journal,
A A Kirichenko, and O A Mantserova, and A Iu Lebedeva, and N V D'iachkova, and N M Voloshina, and V I Mazurov, and V M Nifontov, and V V Tyrenko, and I G Kolina, and A L Cherkashina, and N V Shkodina, and K V Mazalov, and N A Spiropulos, and I A Eremenko, and A I Kuzin
May 2000, The American journal of cardiology,
Copied contents to your clipboard!